BioCentury | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

...a $12.3 million series A round from Data Collective, Draper Esprit, Morningside Group, Providence Investment, Cambridge Consultants...
BioCentury | Feb 2, 2018
Financial News

Evonetix raises $12.3M series A

...by new investors DCVC and Draper Esprit. New investor Morningside and existing investors Providence Investment, Cambridge Consultants...
BioCentury | Dec 15, 2008
Company News

Cambridge Consultants Inc., 3M deal

...Inhaler (DPI) technology. 3M will offer the technology to partners. Financial terms were not disclosed. Cambridge Consultants...
BioCentury | Mar 4, 2002
Company News

Vectura Ltd., Arthur D. Little deal

...Vectura acquired Arthur's Aspirair drug delivery technology and research team for $5 million. Cambridge Consultants, Arthur's European...
Items per page:
1 - 4 of 4
BioCentury | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

...a $12.3 million series A round from Data Collective, Draper Esprit, Morningside Group, Providence Investment, Cambridge Consultants...
BioCentury | Feb 2, 2018
Financial News

Evonetix raises $12.3M series A

...by new investors DCVC and Draper Esprit. New investor Morningside and existing investors Providence Investment, Cambridge Consultants...
BioCentury | Dec 15, 2008
Company News

Cambridge Consultants Inc., 3M deal

...Inhaler (DPI) technology. 3M will offer the technology to partners. Financial terms were not disclosed. Cambridge Consultants...
BioCentury | Mar 4, 2002
Company News

Vectura Ltd., Arthur D. Little deal

...Vectura acquired Arthur's Aspirair drug delivery technology and research team for $5 million. Cambridge Consultants, Arthur's European...
Items per page:
1 - 4 of 4